Download PDF
CC BY 4.0 · Arch Plast Surg 2024; 51(04): 432-440
DOI: 10.1055/a-2317-4520
Research/Experimental
Original Article

Preconditioning Local Injection of Activated Platelet-Rich Plasma Increases Angiogenesis, VEGF Levels, and Viability of Modified McFarlane Flap in Diabetes-Induced Rats

Jenisa Amanda Sandiarini Kamayana 
1   Division of Plastic, Reconstructive and Aesthetic Surgery, Department of Surgery, Udayana University, Bali, Indonesia
,
Agus Roy Rusly Hariantana Hamid 
1   Division of Plastic, Reconstructive and Aesthetic Surgery, Department of Surgery, Udayana University, Bali, Indonesia
,
Tjokorda Gde Bagus Mahadewa 
2   Department of Neurosurgery, Udayana University, Bali, Indonesia
,
I. Gusti Putu Hendra Sanjaya 
1   Division of Plastic, Reconstructive and Aesthetic Surgery, Department of Surgery, Udayana University, Bali, Indonesia
,
I. Made Darmajaya 
3   Division of Paediatric Surgery, Department of Surgery, Udayana University, Bali, Indonesia
,
I. Gusti Ayu Sri Mahendra Dewi 
4   Department of Anatomical Pathology, Udayana University, Bali, Indonesia
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Background The risk of flap necrosis in tissue reconstruction surgery is elevated in patients with vascular disorders, such as diabetes mellitus. Chronic hyperglycemia causes endothelial cell dysfunction and increases inflammatory process, causing vascular insufficiency. Platelet-rich plasma (PRP) contains high levels of platelets, growth factors, and fibrinogens. Its regenerative properties spark interest in supporting flap survival in relation to diabetic complications.

Methods Thirty Wistar rats were divided into three groups. The first group included diabetic rats without PRP injection, which underwent flap procedure. The second group included diabetes-induced rats receiving PRP subcutaneous injection 1 day prior to flap procedure. The third group included nondiabetic rats receiving PRP injection 1 day prior to flap procedure. Flap tissue samples were taken on the seventh day to measure vascular endothelial growth factor (VEGF) levels using enzyme-linked immunosorbent assay method; angiogenesis and collagen density were measured from histopathology examination, and flap viability was analyzed using digital measurements.

Results Analysis showed that flap viability, angiogenesis, and VEGF levels were significantly higher in the PRP-injected diabetic rats compared with diabetic rats that did not receive PRP. The levels of VEGF, angiogenesis, and viability of flaps in diabetic rats given PRP did not differ significantly compared with nondiabetic rats that received PRP.

Conclusion Flap preconditioning through local injection of activated PRP enhances flap viability, VEGF levels and angiogenesis, in random skin flaps in diabetic rats, to the level where it does not differ significantly to nondiabetic rats that were given PRP.

Keywords

platelet-rich plasma - diabetes mellitus - VEGF - angiogenesis - random skin flap

Authors’ Contributions

J.A.S.K.: conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, validation, visualization, writing—original draft, writing—review and editing. A.R.R.H.H.: conceptualization, data curation, formal analysis, investigation, methodology, project administration, supervision, validation, visualization, writing—review and editing. T.G.B.M.: conceptualization, data curation, formal analysis, investigation, methodology, project administration, supervision, validation, visualization, writing—review and editing. I.G.P.H.S.: investigation, methodology, supervision, validation, visualization, writing—review and editing. I.M.D.: investigation, methodology, supervision, validation, visualization, writing—review and editing. I.G.A.S.M.D: investigation, methodology, supervision, validation, visualization, writing—review and editing


Ethical Approval

Ethical clearance for this study was obtained from The Research Ethics Committee of the pertinent institution, with approval number 3135/UN14.2.2.VII.14/LT/2022.


Patient Consent

No patient was involved in this study.


Note

This study was a thesis paper for a residency program in Plastic, Reconstructive and Aesthetic Surgery.


This study was presented at an international meeting, which was the 26th Annual Scientific Meeting of Indonesian Association of Plastic Reconstructive and Aesthetic Surgeons on August 23, 2023, in Manado, North Sulawesi, Indonesia.




Publication History

Received: 21 October 2023

Accepted: 28 April 2024

Accepted Manuscript online:
30 April 2024

Article published online:
13 June 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Frydrych LM, Fattahi F, He K, Ward PA, Delano MJ. Diabetes and sepsis: risk, recurrence, and ruination. Front Endocrinol (Lausanne) 2017; 8 (OCT): 271
    CrossrefPubMedGoogle Scholar
  • 2 Rosado P, Cheng HT, Wu CM, Wei FC. Influence of diabetes mellitus on postoperative complications and failure in head and neck free flap reconstruction: a systematic review and meta-analysis. Head Neck 2015; 37 (04) 615-618
    CrossrefPubMedGoogle Scholar
  • 3 Hasiba-Pappas SK, Tuca AC, Luze H. et al. Platelet-rich plasma in plastic surgery: a systematic review. Transfus Med Hemother 2022; 49 (03) 129-142
    CrossrefPubMedGoogle Scholar
  • 4 Chai J, Ge J, Zou J. Effect of autologous platelet-rich plasma gel on skin flap survival. Med Sci Monit 2019; 25: 1611-1620
    CrossrefPubMedGoogle Scholar
  • 5 Swendseid B, Vimawala S, Ortlip T. et al. Platelet-rich plasma enhances distal flap viability and underlying vascularity in a radiated rotational flap rodent model. Facial Plast Surg Aesthet Med 2020; 22 (03) 181-187
    CrossrefPubMedGoogle Scholar
  • 6 Wilson RD, Islam MS. Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes. Pharmacol Rep 2012; 64 (01) 129-139
    CrossrefPubMedGoogle Scholar
  • 7 Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004; 91 (01) 4-15
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy 2012; 28 (03) 429-439
    CrossrefPubMedGoogle Scholar
  • 9 McFarlane RM, Deyoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg 1965; 35 (02) 177-182
    CrossrefPubMedGoogle Scholar
  • 10 Nugroho T, Rizaliyana S, Perdanakusuma D. Effectiveness of pre PRP injection and post elevation flap at extended random flap rat skin. Folia Medica Indones. 2021; 56 (03) 186
    CrossrefGoogle Scholar
  • 11 Ni X, Shan X, Xu L. et al. Adipose-derived stem cells combined with platelet-rich plasma enhance wound healing in a rat model of full-thickness skin defects. Stem Cell Res Ther 2021; 12 (01) 226
    CrossrefPubMedGoogle Scholar
  • 12 van den Heuvel MGW, Buurman WA, Bast A, van der Hulst RRWJ. Review: Ischaemia-reperfusion injury in flap surgery. J Plast Reconstr Aesthet Surg 2009; 62 (06) 721-726
    CrossrefPubMedGoogle Scholar
  • 13 Baldea BI, Toader S, Orbai P. et al. The influence of diabetes mellitus on survival of abdominal perforator flaps: an experimental study in rats with slowly induced diabetes mellitus. J Reconstr Microsurg 2015; 31 (02) 145-153
    PubMedGoogle Scholar
  • 14 Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes 2017; 9 (05) 434-449
    CrossrefPubMedGoogle Scholar
  • 15 Fibrini D, Lister INE, Rosadi I. Autologous platelet-rich plasma in the management of diabetic foot ulcer: a systematic review of randomized controlled trials. J Ski Stem Cell. 2022; 9 (02) 1-7
    Google Scholar
  • 16 Katanyoo K, Rongsriyam K, Chongtanakon M. Association between pretreatment levels of serum vascular endothelial growth factor (VEGF) and survival outcomes in locally advanced cervical cancer patients. J Cancer Ther 2013; 4 (10) 1478-1484
    CrossrefGoogle Scholar
  • 17 Sun Y, Li QF, Zhang Y, Hu R, Jiang H. Isoflurane preconditioning increases survival of rat skin random-pattern flaps by induction of HIF-1α expression. Cell Physiol Biochem 2013; 31 (4–5): 579-591
    CrossrefPubMedGoogle Scholar
  • 18 Mahdy RA, Nada WM, Hadhoud KM, El-Tarhony SA. The role of vascular endothelial growth factor in the progression of diabetic vascular complications. Eye (Lond) 2010; 24 (10) 1576-1584
    CrossrefPubMedGoogle Scholar
  • 19 Jiang Z, Li X, Chen M, Lu L, Gong X. Effect of endogenous vascular endothelial growth factor on flap surgical delay in a rat flap model. Plast Reconstr Surg 2019; 143 (01) 126-135
    CrossrefPubMedGoogle Scholar
  • 20 Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver WC, Buncke HJ. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 2000; 53 (03) 234-239
    CrossrefPubMedGoogle Scholar
  • 21 Cheng H, Zhang J, Li J, Jia M, Wang Y, Shen H. Platelet-rich plasma stimulates angiogenesis in mice which may promote hair growth. Eur J Med Res 2017; 22 (01) 39
    CrossrefPubMedGoogle Scholar
  • 22 Ebrahim N, Dessouky AA, Mostafa O. et al. Adipose mesenchymal stem cells combined with platelet-rich plasma accelerate diabetic wound healing by modulating the Notch pathway. Stem Cell Res Ther 2021; 12 (01) 392
    CrossrefPubMedGoogle Scholar
  • 23 Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg 2017; 38: 206-211
    CrossrefPubMedGoogle Scholar
  • 24 Khaled I, Abdel-Messih I, Hamza M, Toema S, El-Shishtawy N. Comparative analysis of different activation methods on platelet rich plasma title. Merit Res J Med Med Sci. 2020; 8 (03) xxx-xxx
    Google Scholar
  • 25 Nouh AH, Abdelaal AM, Fathy AES. Activated platelet rich plasma versus non-activated platelet rich plasma in the treatment of alopecia areata. Skin Appendage Disord 2023; 9 (01) 42-49
    CrossrefPubMedGoogle Scholar
  • 26 Qian Z, Wang H, Bai Y. et al. Improving chronic diabetic wound healing through an injectable and self-healing hydrogel with platelet-rich plasma release. ACS Appl Mater Interfaces 2020; 12 (50) 55659-55674
    CrossrefPubMedGoogle Scholar
  • 27 Pawar RS, Kumar S, Toppo FA, PK L, Suryavanshi P. Sida cordifolia Linn. accelerates wound healing process in type 2 diabetic rats. J Acute Med 2016; 6 (04) 82-89
    CrossrefGoogle Scholar
  • 28 Monnier VM, Mustata GT, Biemel KL. et al. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on “a puzzle nearing resolution”. Ann N Y Acad Sci 2005; 1043: 533-544
    CrossrefPubMedGoogle Scholar
  • 29 Patel S, Srivastava S, Singh MR, Singh D. Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother 2019; 112 (January): 108615
    CrossrefPubMedGoogle Scholar
  • 30 Cho EB, Park GS, Park SS. et al. Effect of platelet-rich plasma on proliferation and migration in human dermal fibroblasts. J Cosmet Dermatol 2019; 18 (04) 1105-1112
    CrossrefPubMedGoogle Scholar